Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy.

Ranganathan AC, Adam AP, Aguirre-Ghiso JA.

Cell Cycle. 2006 Aug;5(16):1799-807. Epub 2006 Aug 15. Review.

2.

[Tumor dormancy and identification of therapeutic targets].

Li CF, Cao S, Meng SD.

Ai Zheng. 2009 May;28(5):555-8. Review. Chinese.

PMID:
19624889
3.

ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.

Sosa MS, Avivar-Valderas A, Bragado P, Wen HC, Aguirre-Ghiso JA.

Clin Cancer Res. 2011 Sep 15;17(18):5850-7. doi: 10.1158/1078-0432.CCR-10-2574. Epub 2011 Jun 14. Review.

4.

Tumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells?

Ranganathan AC, Adam AP, Zhang L, Aguirre-Ghiso JA.

Cancer Biol Ther. 2006 Jul;5(7):729-35. Epub 2006 Jul 1. Review.

6.

The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?

Allgayer H, Aguirre-Ghiso JA.

APMIS. 2008 Jul-Aug;116(7-8):602-14. doi: 10.1111/j.1600-0463.2008.00997.x. Review.

7.

Addressing the role of cell adhesion in tumor cell dormancy.

White DE, Rayment JH, Muller WJ.

Cell Cycle. 2006 Aug;5(16):1756-9. Epub 2006 Aug 15. Review.

PMID:
16880738
8.

Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.

Bleau AM, Agliano A, Larzabal L, de Aberasturi AL, Calvo A.

Histol Histopathol. 2014 Dec;29(12):1499-510. doi: 10.14670/HH-29.1499. Epub 2014 Jun 2. Review.

PMID:
24887025
9.

The Relationship Between Dormant Cancer Cells and Their Microenvironment.

Linde N, Fluegen G, Aguirre-Ghiso JA.

Adv Cancer Res. 2016;132:45-71. doi: 10.1016/bs.acr.2016.07.002. Epub 2016 Aug 25. Review.

10.

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

Li J, Jiang E, Wang X, Shangguan AJ, Zhang L, Yu Z.

Cell Biochem Biophys. 2015 Jun;72(2):317-20. doi: 10.1007/s12013-014-0477-4. Review.

PMID:
25556072
11.

Regulation of tumor cell dormancy by tissue microenvironments and autophagy.

Sosa MS, Bragado P, Debnath J, Aguirre-Ghiso JA.

Adv Exp Med Biol. 2013;734:73-89. doi: 10.1007/978-1-4614-1445-2_5. Review.

12.

Models, mechanisms and clinical evidence for cancer dormancy.

Aguirre-Ghiso JA.

Nat Rev Cancer. 2007 Nov;7(11):834-46. Review.

13.

Microenvironments dictating tumor cell dormancy.

Bragado P, Sosa MS, Keely P, Condeelis J, Aguirre-Ghiso JA.

Recent Results Cancer Res. 2012;195:25-39. doi: 10.1007/978-3-642-28160-0_3. Review.

14.

Molecular pathways: niches in metastatic dormancy.

Yumoto K, Eber MR, Berry JE, Taichman RS, Shiozawa Y.

Clin Cancer Res. 2014 Jul 1;20(13):3384-9. doi: 10.1158/1078-0432.CCR-13-0897. Epub 2014 Apr 22. Review.

15.

Clinical opportunities and challenges in targeting tumour dormancy.

Hensel JA, Flaig TW, Theodorescu D.

Nat Rev Clin Oncol. 2013 Jan;10(1):41-51. doi: 10.1038/nrclinonc.2012.207. Epub 2012 Nov 27. Review.

PMID:
23183631
16.

Mechanisms of Metastatic Tumor Dormancy.

Osisami M, Keller ET.

J Clin Med. 2013 Sep 23;2(3):136-50. doi: 10.3390/jcm2030136. Review.

17.

Mechanisms of disseminated cancer cell dormancy: an awakening field.

Sosa MS, Bragado P, Aguirre-Ghiso JA.

Nat Rev Cancer. 2014 Sep;14(9):611-22. doi: 10.1038/nrc3793. Epub 2014 Aug 14. Review.

18.

Mechanisms governing metastatic dormancy and reactivation.

Giancotti FG.

Cell. 2013 Nov 7;155(4):750-64. doi: 10.1016/j.cell.2013.10.029. Review.

19.

Dormancy in breast cancer.

Banys M, Hartkopf AD, Krawczyk N, Kaiser T, Meier-Stiegen F, Fehm T, Neubauer H.

Breast Cancer (Dove Med Press). 2012 Dec 5;4:183-91. doi: 10.2147/BCTT.S26431. Review.

20.

Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.

Muzes G, Sipos F.

Anticancer Agents Med Chem. 2017;17(4):472-482. doi: 10.2174/1871520616666160901145857. Review.

PMID:
27592547

Supplemental Content

Support Center